This federal contract opportunity has been awarded to on February 12, 2024.
DEPT OF DEFENSE awarded this contract to for $6,984,110 on February 12, 2024, as part of federal procurement initiatives.
This award is part of federal acquisition procurement activities.
Modification SPE2D224D0003 P00002 to exercise Option Year 1 effective February 12, 2025 through February 11, 2026. Modification SPE2D224D0003 P00001 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract.
The Department of DEFENSE is seeking responses for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.
Looking for more opportunities?
Browse our full directory of government contracts